Medicina
Departamento
Albert Einstein College of Medicine
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Albert Einstein College of Medicine (23)
2023
-
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC
JTO Clinical and Research Reports, Vol. 4, Núm. 1
-
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study
Journal of Clinical Oncology, Vol. 41, Núm. 11, pp. 1999-2006
-
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience
Clinical Genitourinary Cancer, Vol. 21, Núm. 5, pp. 584-593
2022
-
Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis
JACC: Cardiovascular Imaging, Vol. 15, Núm. 11, pp. 1883-1896
2021
-
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis
Journal of the American College of Cardiology, Vol. 77, Núm. 12, pp. 1503-1516
-
Recurrence of iga nephropathy after kidney transplantation in adults
Clinical Journal of the American Society of Nephrology, Vol. 16, Núm. 8, pp. 1247-1255
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)
International Journal of Cardiology, Vol. 299, pp. 49-55
2019
-
Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study
Journal of Clinical Oncology
-
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
npj Breast Cancer, Vol. 5, Núm. 1
-
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation
Journal of Experimental Medicine, Vol. 216, Núm. 5, pp. 1061-1070
2018
-
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 1, pp. 115-126
-
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors
Oncologist, Vol. 23, Núm. 7, pp. 766-e90
2017
-
Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y
World Journal of Emergency Surgery
-
Rationale and design of a multicenter, international and collaborative Coronary Artery Aneurysm Registry (CAAR)
Clinical Cardiology, Vol. 40, Núm. 8, pp. 580-585
2016
-
Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
World Journal of Emergency Surgery, Vol. 11, Núm. 1
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
-
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
JACC: Cardiovascular Interventions, Vol. 9, Núm. 12, pp. 1231-1242
2014
-
Glycated hemoglobin measurement and prediction of cardiovascular disease
JAMA - Journal of the American Medical Association, Vol. 311, Núm. 12, pp. 1225-1233